| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |